Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula (unspecified eye)
ICD-10 E10.3529 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula (unspecified eye).
E10.3529 refers to a specific complication of Type 1 diabetes mellitus characterized by proliferative diabetic retinopathy (PDR) that has progressed to include traction retinal detachment involving the macula in an unspecified eye. PDR is a severe form of diabetic retinopathy where new, abnormal blood vessels grow on the retina, which can lead to vision loss. The presence of traction retinal detachment indicates that these abnormal vessels are pulling on the retina, potentially causing it to detach from the underlying tissue. This condition is often associated with poorly controlled blood glucose levels over time, leading to elevated HbA1c levels. Management typically involves strict glycemic control, regular ophthalmologic evaluations, and may require surgical intervention to repair the retinal detachment. The complexity of coding this condition arises from the need to accurately document the type of diabetes, the specific complications, and the affected eye.
Detailed records of diabetes management, including HbA1c levels and treatment plans.
Patients with poorly controlled diabetes presenting with complications.
Ensure comprehensive documentation of diabetes control and related complications.
Thorough examination notes detailing retinal findings and treatment plans.
Patients with diabetic retinopathy requiring surgical intervention.
Accurate description of retinal findings and surgical procedures performed.
Used for surgical intervention in cases of traction retinal detachment.
Operative report detailing the procedure and findings.
Ophthalmology must document the indication for surgery and pre-operative assessments.
Specifying the affected eye is crucial for accurate coding and treatment planning, as it impacts the management and potential surgical interventions required for the patient.
HbA1c levels provide insight into the patient's diabetes control and can influence the severity of the complications coded. Higher levels may indicate a more severe condition, warranting specific coding.
